Clinical Trial Update: Ancillary Longitudinal CSF Collection Study in the Harvard Biomarker Study - HBS2

View source ↗

Summary

This entry describes an ancillary longitudinal cerebrospinal fluid collection study within the Harvard Biomarker Study (HBS2). It is sponsored by Brigham and Wo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Parkinson's Disease | Status: UNKNOWN